Cargando...
Withdrawal effects confounding in clinical trials: another sign of a needed paradigm shift in psychopharmacology research
Randomized controlled trials’ ability to produce evidence useful for people to decide whether to take, continue taking, or stop taking psychotropic drugs has been intensely critiqued, along with the trials’ commercial, ideological, and regulatory contexts. This article applies the critique to the to...
Guardado en:
| Publicado en: | Ther Adv Psychopharmacol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7656873/ https://ncbi.nlm.nih.gov/pubmed/33224467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125320964097 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|